Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others

Departments of *Pathology

†Oncology

∥Urology, The Johns Hopkins Medical Institutions, Baltimore

‡Translational Surgical Pathology, Laboratory of Pathology, National Institutes of Health, Bethesda, MD

§Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY

Conflicts of Interest and Source of Funding: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Correspondence: Andres Matoso, MD, The Johns Hopkins Hospital, The Weinberg Building, Room 2242, 401 North Broadway Street, Baltimore, MD 21231 (e-mail: [email protected]).

Comments (0)

No login
gif